Alexandra J. McCormack
Alexandra J. McCormack’s practice focuses on mergers and acquisitions, private equity, and other securities and corporate law matters.

Bio

Ms. McCormack advises public and private companies, private equity firms, and investment banks in U.S. and cross-border acquisitions, divestitures, mergers of equals, joint ventures and other transactions, including:

  • NXP Semiconductors N.V. (Netherlands) in its $47 billion pending acquisition by Qualcomm Incorporated;
  • WellDyne, Inc. in its sale of pharmacy benefit manager WellDyneRx, Inc. to The Carlyle Group;
  • Permira Funds in its acquisition of Lyophilization Services of New England, Inc.;
  • Rite Aid Corporation in its pending acquisition by Walgreens Boots Alliance, Inc.; and its $2 billion acquisition of EnvisionRx from TPG Capital and other owners;
  • Freescale Semiconductor, Ltd. (and The Blackstone Group, The Carlyle Group, Permira Funds and TPG Capital) in Freescale’s merger with NXP Semiconductors N.V. (Netherlands) for a combined enterprise value of $40 billion;
  • Cobham plc (United Kingdom) in its $1.46 billion acquisition of Aeroflex Holding Corp.;
  • Sentinel Capital Partners in its acquisition of Hollander Sleep Products from HGGC (previously known as Huntsman Gay Global Capital) and other owners;
  • the independent directors of Chrysler Group LLC in the $4.35 billion acquisition by Fiat S.p.A. (Italy) of the minority interests owned by the UAW Retiree Medical Benefits Trust;
  • Sprint Nextel Corporation in its $20.1 billion sale of a 78 percent stake to SoftBank Corp. (Japan) (The American Lawyer’s Global M&A Deal of the Year: Grand Prize; the Financial Times’ 2013 U.S. “Innovative Lawyers” report — Corporate & Commercial category; and largest-ever overseas acquisition by a Japanese company);
  • Gardner Denver, Inc. in its $3.9 billion acquisition by Kohlberg Kravis Roberts & Co. L.P.;
  • Dell Inc. in its $2.4 billion acquisition of Quest Software, Inc;
  • The NASDAQ OMX Group, Inc. in its divestiture of International Derivatives Clearing Group, LLC to LCH.Clearnet Group Limited (United Kingdom);
  • Valeant Pharmaceuticals International in its $3.5 billion merger with Biovail Corporation (Canada) (The Globe and Mail’s 2010 Health Care Deal of the Year);
  • Inversiones de Guatemala S.A. (Guatemala) in the divestiture of 50 percent of its Zacapa branded rum business to Diageo plc (United Kingdom);
  • Foundation Coal Holdings, Inc. in its $2 billion acquisition by Alpha Natural Resources, Inc.;
  • Centennial Communications Corp. in its $2.7 billion acquisition by AT&T Inc.;
  • The NASDAQ OMX Group, Inc. in its formation of The Portal Alliance LLC, a trading platform for 144A securities, together with nine leading securities firms;
  • Crown Limited (Australia) in the termination of its $1.7 billion agreement to acquire Cannery Casino Resorts, LLC from Oaktree Capital Management, L.P. and subsequent $320 million preferred investment;
  • The Broad Institute, Inc. in its genomic research joint venture with the Eli and Edythe Broad Foundation, Harvard University and the Massachusetts Institute of Technology;
  • MetroPCS Communications, Inc. in its $5.5 billion proposal to acquire Leap Wireless International, Inc.;
  • Fisher Scientific International Inc. in its $12.8 billion merger with Thermo Electron Corporation; $283 million acquisition of Athena Diagnostics, Inc. from Behrman Capital and management stockholders; and $3.7 billion merger with Apogent Technologies Inc.;
  • Citigroup Inc. in the $3.7 billion exchange of its asset management business for the private client and capital markets businesses of Legg Mason, Inc.; and
  • Penn National Gaming, Inc. in its $2.2 billion acquisition of Argosy Gaming Company.

Ms. McCormack also advises the firm’s investment banking clients in transactional and financial advisory work.

In 2016, Ms. McCormack received an M&A Advisor "Emerging Leaders Award" (formerly "40 Under 40").

Credentials

Education

  • J.D., Harvard Law School, 2003
  • A.B., Harvard University, Harvard College, 2000 (magna cum laude, with highest honors in Literature)

Admissions

  • Massachusetts
  • New York

Alexandra J. McCormack

Partner, Mergers and Acquisitions, Private Equity
alexandra.mccormack@skadden.com